Sign inJoin waitlistJoin the waitlist

Gayathri Nagaraj

Associate Professor · Loma Linda University Health Education Consortium

Credentials: · · · · ·

History

Loma Linda University Health Education Consortium
Present

Hematology and Medical Oncology
Washington University School of Medicine
2005–2008
Drexel University College of Medicine/Hahnemann University
2002–2005
BANGALORE MED COLL, BANGALORE UNIV, BANGALORE, KARNATAKA, INDIA
1998–2002

Research

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Annals of Oncology · 2021 · 260 citations
COVID-19 vaccination and breakthrough infections in patients with cancer
Annals of Oncology · 2022 · 88 citations
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Clinical Cancer Research · 2016 · 81 citations

Jeremy Warner
11 papers
Rana McKay
11 papers · 2 as a resident
Clara Hwang
10 papers
MP
Matthew Puc
10 papers
Babar Bashir
9 papers
Chris Labaki
9 papers · 1 as a resident
Stephanie Berg
8 papers
Vadim Koshkin
8 papers
Daniel Kwon
7 papers · 3 as a fellow
Elizabeth Wulff
7 papers
HP
Hyma Polimera
7 papers · 6 as a fellow
Mehmet Bilen
7 papers

Clinical trials

Effect of Resveratrol on Serum IGF2 Among African American Women
Principal investigator · Withdrawn
Loma Linda University
2019–2022
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Principal investigator · Completed
Loma Linda University
2017–2022
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Site PI · Recruiting
Natera, Inc.
2026–2037
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037